Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 03:41:27 2024-05-09 pm EDT			5-day change	1st Jan Change
251 ^USD	+0.56%		+1.68%	+8.49%

07:20pm	Danaher, Johns Hopkins University to Develop Neurological Diagnostics	MT
01:00pm	Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis	CI

Danaher Corporation Reports Earnings Results for the Full Year Ended December 31, 2023

January 30, 2024 at 06:00 am EST

Danaher Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 23,890 million compared to USD 26,643 million a year ago. Net income was USD 4,764 million compared to USD 7,209 million a year ago.

Basic earnings per share from continuing operations was USD 5.7 compared to USD 8.58 a year ago. Diluted earnings per share from continuing operations was USD 5.65 compared to USD 8.47 a year ago. Basic earnings per share was USD 6.44 compared to USD 9.8 a year ago.

Diluted earnings per share was USD 6.38 compared to USD 9.66 a year ago.

Latest news about Danaher Corporation

Danaher, Johns Hopkins University to Develop Neurological Diagnostics	01:20pm	MT
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis	07:00am	CI
Danaher Keeps Quarterly Dividend at $0.27 a Share, Payable July 26 to Shareholders of Record June 28	May. 07	MT
Danaher Announces Quarterly Dividend, Payable on July 26, 2024	May. 07	CI
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating	Apr. 29	MT
Danaher Insider Sold Shares Worth $5,618,569, According to a Recent SEC Filing	Apr. 26	MT
Danaher Insider Sold Shares Worth $11,756,725, According to a Recent SEC Filing	Apr. 25	MT
Danaher Insider Sold Shares Worth $1,000,040, According to a Recent SEC Filing	Apr. 25	MT
HSBC Adjusts Danaher's Price Target to $290 From $280	Apr. 24	MT
TD Cowen Adjusts Price Target on Danaher to $290 From $280	Apr. 24	MT
Barclays Adjusts Price Target on Danaher to $270 From $260	Apr. 24	MT
Citigroup Adjusts Price Target on Danaher to $290 From $280	Apr. 24	MT
Baird Adjusts Danaher Price Target to $271 From $259	Apr. 24	MT
Leerink Partners Adjusts Danaher Price Target to $275 From $265	Apr. 24	MT
RBC Raises Price Target on Danaher to $297 From $284, Keeps Outperform Rating	Apr. 24	MT
Veralto beats Q1 results on strength in water quality unit	Apr. 23	RE
Sector Update: Health Care Stocks Rise Late Afternoon	Apr. 23	MT
S&P 500 gains as investors digest positive earnings, megacap results outlook	Apr. 23	RE
Goldman Sachs Raises Danaher Price Target to $220 from $215	Apr. 23	MT
Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock	Apr. 23	MT
Evercore ISI Adjusts Price Target on Danaher to $266 From $260	Apr. 23	MT
Danaher Shares Rise After Reporting Fiscal Q1 Adjusted Earnings, Sales Decline	Apr. 23	MT
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	Apr. 23	MT
Traders Eye Tesla, Other Big Tech Earnings, Driving Muted Premarket Action for US Equity Futures	Apr. 23	MT
Futures point to higher open as more earnings roll in	Apr. 23	RE

Chart Danaher Corporation

Duration

Period

More charts

Company Profile

Danaher Corporation is an industrial and technologic group organized around two families of products: - medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.; - professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc. Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-14 - Bank of America Securities Health Care Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Danaher Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

249.6 USD

Average target price

272.7 USD

Spread / Average Target

+9.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
DANAHER CORPORATION	+8.49%	185B
THERMO FISHER SCIENTIFIC	+8.65%	219B
INTUITIVE SURGICAL, INC.	+14.24%	135B
BOSTON SCIENTIFIC CORPORATION	+27.63%	107B
EDWARDS LIFESCIENCES CORPORATION	+14.69%	51.28B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.48%	51.01B
AGILENT TECHNOLOGIES, INC.	+4.39%	41.85B
GE HEALTHCARE TECHNOLOGIES INC.	+6.63%	37.02B
RESMED, INC.	+25.93%	31.27B
PHILIPS NV	+16.53%	23.66B

Other Advanced Medical Equipment & Technology